,Rank,NCTId,Phase,Condition,EnrollmentCount,OverallStatus
0,1,NCT00478816,Phase 2,Prophylaxis of Avian Influenza Vaccine,58,Completed
1,2,NCT01718834,Phase 1|Phase 2,Vaccine Overdose of Undetermined Intent,50,Unknown status
2,3,NCT03771157,Early Phase 1,Chronic Lymphocytic Leukemia (CLL)|Waldenstrom Macroglobulinemia (WM),33,Completed
3,4,NCT03057483,,Influenza Vaccines,533,Completed
4,5,NCT00735410,Phase 3,"Seasonal Influenza, Vaccine",134,Completed
5,6,NCT00103116,Phase 2,Lung Cancer,32,Completed
6,7,NCT01215981,Not Applicable,Hematopoietic Stem Cell Transplant|Hematologic Malignancy,68,Terminated
7,8,NCT05875779,Not Applicable,Vaccine Acceptance,154,Completed
8,9,NCT05208983,,COVID-19 Virus Infection|Vaccine Response,1286,"Active, not recruiting"
9,10,NCT05521763,Not Applicable,Influenza Vaccines,3000,Recruiting
10,11,NCT02915302,Phase 4,Influenza,1950,Completed
11,12,NCT01122784,Phase 2,Plague Vaccine,402,Completed
12,13,NCT00841646,Phase 2,Prepandemic Influenza Vaccine,343,Completed
13,14,NCT04548518,Phase 3,Influenza,816,Recruiting
14,15,NCT00560066,Phase 4,Seasonal Influenza|Vaccine,1398,Completed
15,16,NCT00764634,Phase 2,Botulism Vaccine,440,Completed
16,17,NCT04898946,,Covid-19 Vaccine,400,Unknown status
17,18,NCT05531058,Not Applicable,Vaccine Hesitancy|COVID-19,168,Not yet recruiting
18,19,NCT05128721,Phase 1,COVID-19|Vaccine Reaction|Vaccine Adverse Reaction,72,Unknown status
19,20,NCT06104345,Phase 4,Vaccine-Preventable Diseases|Typhoid Fever|Cholera,60,Recruiting
20,21,NCT00654030,Phase 2,Non-Small Cell Lung Cancer,12,Completed
21,22,NCT04110366,Not Applicable,Influenza|Vaccine Virus Shedding,48,Completed
22,23,NCT05593042,Phase 2,COVID-19|Vaccines,826,Recruiting
23,24,NCT00511914,Phase 3,Seasonal Influenza Vaccine,135,Completed
24,25,NCT01394614,,Narcolepsy,24,Completed
25,26,NCT03493776,Phase 4,Varicella Zoster Vaccine,50,Unknown status
26,27,NCT01084291,Phase 1,Dengue Virus,18,Completed
27,28,NCT04770649,,Vaccine Response Impaired|Vaccine Adverse Reaction,10000,Unknown status
28,29,NCT02196285,Phase 1,Rubella|Measles,30,Completed
29,30,NCT06024096,Phase 4,Vaccine Response,60,Recruiting
30,31,NCT01151059,Phase 2,Seasonal Influenza,138,Completed
31,32,NCT00522236,Phase 2,Influenza,56,Completed
32,33,NCT02842866,Phase 3,Meningitis|Meningococcal Meningitis|Meningococcal Infections,907,Completed
33,34,NCT05685953,Phase 1,COVID-19 Respiratory Infection|COVID-19 Vaccine Adverse Reaction,16,Recruiting
34,35,NCT02752906,Phase 3,Meningitis|Meningococcal Meningitis|Meningococcal Infections,810,Completed
35,36,NCT06202703,Not Applicable,Vaccine-Preventable Diseases,5,Recruiting
36,37,NCT04674462,Phase 4,Vaccine Reaction,200,Recruiting
37,38,NCT02709616,Phase 1,Glioblastoma,10,Completed
38,39,NCT05291871,Phase 4,HPV Infection|HPV Vaccine,92,"Active, not recruiting"
39,40,NCT00918268,Phase 2,Influenza Disease,130,Completed
40,41,NCT04963790,Not Applicable,Covid19|COVID-19 Vaccine,7200,Recruiting
41,42,NCT01446978,Phase 2,Vaccine Response Impaired,150,Unknown status
42,43,NCT00306527,Phase 3,Influenza,2235,Completed
43,44,NCT04651790,Phase 3,Covid19|Vaccines,2300,Completed
44,45,NCT05494047,Phase 3,Influenza|Vaccines,1600,Recruiting
45,46,NCT03246230,Not Applicable,Newborn Vaccine Immunogenicity,911,Completed
46,47,NCT05822219,Not Applicable,Rheumatic Diseases|COVID-19 Vaccine|COVID-19|SLE,60,Not yet recruiting
47,48,NCT01976520,Phase 1,Chronic Lymphocytic Leukemia (CLL),30,Unknown status
48,49,NCT00841763,Phase 3,Pandemic Influenza Disease,3647,Completed
49,50,NCT05994820,Not Applicable,Vaccine Hesitancy,1950,Recruiting
50,51,NCT03148990,Phase 2|Phase 3,Rubella|Measles,432,Completed
51,52,NCT01656200,Phase 4,Japanese Encephalitis|Japanese Encephalitis Vaccine,17,Completed
52,53,NCT05506969,Phase 2,"Plague, Pneumonic|Plague|Vaccine-Preventable Diseases",200,"Active, not recruiting"
53,54,NCT00856297,Phase 3,Meningococcal Meningitis,389,Completed
54,55,NCT00518453,Phase 2,Influenza,129,Completed
55,56,NCT05228912,,Vaccine Adverse Reaction|COVID-19|Vaccine Reaction,1870,Completed
56,57,NCT00492063,Phase 3,Influenza,2654,Completed
57,58,NCT05817422,Phase 2,Marburg Virus Disease,125,Not yet recruiting
58,59,NCT04939506,Not Applicable,Covid19|Vaccine Refusal|Vaccine Hesitancy,375,Recruiting
59,60,NCT06036602,Phase 2,Ebola Sudan Virus Disease,125,Not yet recruiting
60,61,NCT00262028,Phase 2,Prevention of Meningococcal Disease,910,Completed
61,62,NCT02388165,Phase 2,Staphylococcal Vaccine,3450,Terminated
62,63,NCT05749926,Phase 3,Vaccine Reaction|COVID-19,248,"Active, not recruiting"
63,64,NCT05185817,Phase 2,Hematopoietic Stem Cell Transplantation (HSCT)|COVID-19 Vaccines|Immune System Tolerance,100,Unknown status
64,65,NCT01716130,,Patient Response to Fluzone ID Vaccine,249,Completed
65,66,NCT00736476,Phase 1,Helicobacter Pylori Infection,63,Completed
66,67,NCT03390166,Phase 2|Phase 3,Influenza,945,Completed
67,68,NCT00498303,Phase 3,Seasonal Influenza|Vaccine,120,Completed
68,69,NCT01119703,,Vaccine Response Impaired,174,Completed
69,70,NCT01195571,Phase 1,Cytomegalovirus,36,Completed
70,71,NCT00569387,Phase 2,Pancreatic Cancer,73,Completed
71,72,NCT01344057,Phase 2,Seasonal Influenza,63,Completed
72,73,NCT04659941,Phase 2,COVID 19 Vaccine,752,"Active, not recruiting"
73,74,NCT02153671,Phase 2,Influenza Vaccine,43,Completed
74,75,NCT01430689,Phase 4,Influenza,4193,Completed
75,76,NCT01717638,Phase 3,Meningococcal Disease|Meningococcal Meningitis,805,Completed
76,77,NCT01043341,Phase 4,Knowledge|Attitude|Behavior,200,Completed
77,78,NCT06186206,Not Applicable,Vaccine Hesitancy,900,Not yet recruiting
78,79,NCT03327987,,Influenza|Solid Organ Transplant,0,Withdrawn
79,80,NCT00433914,Phase 2,Meningococcal Disease,60,Completed
80,81,NCT05012800,Phase 4,COVID-19 Vaccine|Older Adults,300,Unknown status
81,82,NCT00489554,Phase 3,"Infections, Streptococcal|Streptococcus Pneumoniae Vaccines",230,Completed
82,83,NCT01788228,Phase 3,Influenza|Influenza Vaccines,50,Completed
83,84,NCT00408395,Phase 2,Influenza,281,Completed
84,85,NCT02105519,Phase 4,Immunogenicity and Adverse Drug Effect of Vaccines Influenza|Chronic Kidney Disease,200,Unknown status
85,86,NCT04899765,Phase 4,Vaccine Preventable Disease|Measles|Mother-Infant Interaction|BCG Vaccination Reaction,2400,Recruiting
86,87,NCT03587389,Phase 4,Rotavirus|Diarrhea,818,Completed
87,88,NCT05895955,Phase 1|Phase 2,Influenza,290,"Active, not recruiting"
88,89,NCT04741828,Phase 2|Phase 3,Vaccine,188,"Active, not recruiting"
89,90,NCT01519817,Phase 1,Neoplasms|Malignant Solid Tumors|Colon Neoplasms|Adenocarcinoma,34,Completed
90,91,NCT03077438,Phase 3,Meningitis|Meningococcal Meningitis|Meningococcal Infections,1000,Completed
91,92,NCT00630331,Phase 3,Influenza,11404,Completed
92,93,NCT00945841,Phase 3,Seasonal Influenza,126,Completed
93,94,NCT01023776,Phase 4,Influenza,20,Completed
94,95,NCT01224301,Not Applicable,Immunizations|Vaccination|Influenza|School Health,25366,Completed
95,96,NCT05264974,Phase 1,Melanoma,18,Recruiting
96,97,NCT04732819,Not Applicable,COVID-19 Vaccines,23768,Completed
97,98,NCT02806531,Phase 4,Enterovirus 71 Vaccine,20000,Unknown status
98,99,NCT03674073,Phase 1,"Hepatocellular Carcinoma|Liver Cancer, Adult",24,Unknown status
99,100,NCT02842853,Phase 3,Meningitis|Meningococcal Meningitis|Meningococcal Infections,3344,Completed
100,101,NCT01823536,Phase 4,Meningococcal Disease,465,Completed
101,102,NCT00748150,Phase 2,Influenza,143,Completed
102,103,NCT05124171,Phase 3,COVID-19|Vaccine Reaction,247,"Active, not recruiting"
103,104,NCT03603509,Phase 4,Influenza,241,Completed
104,105,NCT01055184,Phase 1|Phase 2,2009 H1N1 Influenza Virus,34,Completed
105,106,NCT00264576,Phase 2,Influenza Disease; Flu,613,Completed
106,107,NCT01700621,Phase 4,Measles Antibody Seroconversion|Rubella Antibody Seroconversion|Rotavirus Geometric Mean Titer (GMT)|Rotavirus Immunoglobulin A (IgA) Seropositivity,482,Completed
107,108,NCT01042951,Phase 2,Healthy,330,Completed
108,109,NCT01654224,Phase 4,Influenza,205,Completed
109,110,NCT03139565,Phase 3,Influenza|Immunosuppression,172,Completed
110,111,NCT05192460,Not Applicable,Gastric Cancer|Esophageal Cancer|Liver Cancer,30,Recruiting
111,112,NCT00614601,Phase 2,Pancreatic Cancer,9,Terminated
112,113,NCT04775563,,Covid19,891,Completed
113,114,NCT01446718,,Human Papillomavirus|HIV-1 Infection,179,Completed
114,115,NCT01376505,Phase 1,Malignant Solid Tumour|Breast Cancer|Malignant Tumor of Colon|GIST|Ovarian Cancer,65,Completed
115,116,NCT03734237,Phase 4,Influenza|Influenza-like Illness|Influenza Vaccines,15449,"Active, not recruiting"
116,117,NCT00767364,Phase 1,Short Bowel Syndrome,8,Completed
117,118,NCT01867021,Phase 4,Influenza,2902,Completed
118,119,NCT05490329,Not Applicable,COVID-19|Vaccine Uptake,360,Completed
119,120,NCT05656508,Phase 1,COVID-19 Vaccine,80,Completed
120,121,NCT05975060,Phase 2|Phase 3,COVID-19,660,Recruiting
121,122,NCT00384670,Phase 1|Phase 2,Dengue Fever,7,Completed
122,123,NCT00956449,Phase 2,Influenza|Seasonal Influenza,126,Completed
123,124,NCT01152814,Phase 2,Seasonal Influenza,64,Completed
124,125,NCT04568590,Not Applicable,Vaccine Refusal,510,Completed
125,126,NCT00829608,Early Phase 1,Recurrent Respiratory Papillomatosis,0,Withdrawn
126,127,NCT00644540,Phase 2,FLU,89,Completed
127,128,NCT01451086,Phase 3,Healthy,1200,Completed
128,129,NCT05069454,Not Applicable,Vaccine Refusal|Covid19,1500,Unknown status
129,130,NCT02203357,Phase 4,Hepatitis B,353,Completed
130,131,NCT05359354,Not Applicable,Solid Tumor,36,Recruiting
131,132,NCT03685682,Phase 3,Varicella Zoster Vaccine,23,Completed
132,133,NCT00997607,Phase 1,Ebola Virus Disease|Marburg Virus Disease,108,Completed
133,134,NCT01666782,Phase 2,Cancer|Influenza Viral Infections,105,Completed
134,135,NCT02177032,Phase 3,Rabies Infection,885,Completed
135,136,NCT01531530,Phase 1,Shigella,26,Completed
136,137,NCT05721456,Phase 3,Pneumococcal Vaccines,2400,Not yet recruiting
137,138,NCT02436928,Phase 1|Phase 2,H7N9 Influenza Vaccine,200,Completed
138,139,NCT02708173,Phase 1,Quadrivalent Influenza Virus Vaccine,40,Completed
139,140,NCT01910519,Phase 2,"Influenza A Virus, H5N1 Subtype",50,Completed
140,141,NCT02765126,Not Applicable,Heterologous Effects of Vaccines,450,Unknown status
141,142,NCT01865968,Phase 4,Hepatitis A,239,Completed
142,143,NCT02229357,Phase 2,Avian Influenza,60,Completed
143,144,NCT04936997,Early Phase 1,Covid19|Cancer|Malignancy|Vaccine Response Impaired,20,Completed
144,145,NCT04885907,Phase 4,Vaccine Response Impaired|Immune Suppression|Covid19,120,Completed
145,146,NCT01525004,Phase 1,Pediatric Solid Organ Transplant Patients,38,Completed
146,147,NCT02263027,Phase 4,Influenza,11,Completed
147,148,NCT01812135,Phase 2,"Infection, Viral, Enterovirus",0,Withdrawn
148,149,NCT00748813,Phase 2,Seasonal Influenza,133,Completed
149,150,NCT02808364,Phase 1,Glioblastoma,10,Completed
150,151,NCT01717118,Phase 4,Healthy,2000,Completed
151,152,NCT04984408,Phase 3,COVID-19 Disease,8825,Not yet recruiting
152,153,NCT05022329,Phase 2|Phase 3,Chronic Kidney Diseases|COVID-19,268,Terminated
153,154,NCT00297817,Phase 2,Meningococcal Disease,203,Completed
154,155,NCT01651104,Phase 2,Human Influenza,63,Completed
155,156,NCT01684072,Phase 4,Chickenpox|Zoster,1200,Completed
156,157,NCT05741242,Phase 1|Phase 2,Cancer|Solid Tumor,20,Enrolling by invitation
157,158,NCT01498718,Phase 1,Influenza,131,Completed
158,159,NCT04450940,Not Applicable,Evaluating Impact of PACV on Vaccine Hesitancy Among Parents of Newborns,1705,Completed
159,160,NCT05212792,,Vaccine Adverse Reaction,6325,Recruiting
160,161,NCT00848029,Phase 3,Pre-pandemic Influenza Vaccine,240,Completed
161,162,NCT00787826,Phase 2,Tularemia,1000,Unknown status
162,163,NCT06006858,,COVID-19,1284,Completed
163,164,NCT06000397,Not Applicable,Pneumococcal Vaccines|Immunization Coverage,700,Recruiting
164,165,NCT01719679,Not Applicable,School Located Vaccine Program,2000,Completed
165,166,NCT00322049,Phase 1|Phase 2,Dengue,51,Completed
166,167,NCT03133923,Phase 2,"Epidemic Parotitis,Mumps",1080,"Active, not recruiting"
167,168,NCT02270944,Phase 2,"Infections, Streptococcal|Streptococcal Infections",1053,Completed
168,169,NCT01140009,Phase 2,Influenza,324,Completed
169,170,NCT01973218,Phase 3,Meningococcal Disease,264,Completed
170,171,NCT02458183,Phase 3,Diphtheria|Tetanus|Pertussis|Poliomyelitis,476,Completed
171,172,NCT00735020,Phase 1,Influenza,72,Completed
172,173,NCT01640314,Phase 3,Influenza,126,Completed
173,174,NCT04969263,Phase 2,Kidney Transplant Recipients,81,Completed
174,175,NCT02231632,Phase 2|Phase 3,Poliomyelitis,1200,Completed
175,176,NCT00518726,Phase 2,Influenza,125,Completed
176,177,NCT05124509,,COVID-19|SARS-CoV-2 Infection|Solid Organ Transplant|Vaccine Response Impaired,147,Completed
177,178,NCT00310817,Phase 2,Meningococcal Meningitis,623,Completed
178,179,NCT01214850,Phase 3,N. Meningitidis Carriage,2968,Completed
179,180,NCT04227210,Phase 1,Respiratory Syncytial Virus Infections,20,Completed
180,181,NCT02750202,Phase 3,Genital Warts,75,"Active, not recruiting"
181,182,NCT00514904,Phase 3,"Infections, Meningococcal|Meningococcal Vaccines",1504,Completed
182,183,NCT05739474,Phase 3,"Influenza|Influenza, Human|Influenza Viral Infections|Vaccine Reaction",948,Recruiting
183,184,NCT01736709,Phase 4,Influenza,202,Completed
184,185,NCT05876377,,SARS-CoV-2|COVID-19|Post-Acute COVID-19 Syndrome,999,Recruiting
185,186,NCT00450437,Phase 3,Meningococcal Infections|Meningococcal Meningitis,3539,Completed
186,187,NCT00721396,Phase 2,Meningococcal Infections,1885,Completed
187,188,NCT00262041,Phase 2,Prevention of Meningococcal Disease,524,Completed
188,189,NCT02759991,Phase 4,Hepatitis E Infection,19460,Completed
189,190,NCT00617851,Phase 3,Influenza,1507,Completed
190,191,NCT00956761,Phase 2,Seasonal Influenza,63,Completed
191,192,NCT06088745,Phase 3,Vaccine-Preventable Diseases|Herpes Zoster,4,Recruiting
192,193,NCT01072734,Phase 2,Systemic Lupus Erythematosus (SLE),28,Completed
193,194,NCT01357265,Phase 2,Influenza,125,Completed
194,195,NCT05028257,Phase 3,Anaphylactic Reaction|Vaccine Reaction,120,Unknown status
195,196,NCT02560909,Phase 4,Transplantation|Influenza Vaccines,73,Completed
196,197,NCT01311024,,Pneumococcal Infections,2341,Completed
197,198,NCT05967650,Not Applicable,Inflammatory Bowel Diseases,200,Not yet recruiting
198,199,NCT00936962,Phase 4,Meningococcal Sero-type C Infection,452,Completed
199,200,NCT01897402,Phase 2,Meningococcal Meningitis|Meningococcal Infections,525,Completed
200,201,NCT01644721,Phase 4,Measles Vaccine,3750,Unknown status
201,202,NCT05071313,Phase 3,"Influenza, Human Prevention|Respiratory Syncytial Viruses Prevention",777,Completed
202,203,NCT00329849,Phase 3,Meningococcal Disease,1500,Completed
203,204,NCT03315975,Phase 4,Viral Vaccines,40,"Active, not recruiting"
204,205,NCT03964415,Phase 3,Healthy,3900,Completed
205,206,NCT05236270,Not Applicable,COVID-19|Vaccine Refusal,2000,Recruiting
206,207,NCT04551248,,Pneumococcal Vaccine Adverse Reaction,1000000,Unknown status
207,208,NCT02093260,Phase 2|Phase 3,Healthy,405,Completed
208,209,NCT00734734,Phase 2,Interpandemic Influenza,64,Completed
209,210,NCT00992212,Phase 2,Pandemic Influenza Disease,418,Completed
210,211,NCT05676970,Not Applicable,Vaccine Hesitancy,525,Not yet recruiting
211,212,NCT00473967,Phase 1,Hookworm Infection,9,Terminated
212,213,NCT00970203,Phase 2,"Cancer of Prostate|Cancer of the Prostate|Neoplasms, Prostate|Neoplasms, Prostatic|Prostate Cancer|Prostate Neoplasms|Prostatic Cancer",13,Completed
213,214,NCT02083068,Phase 2,Malaria,32,Completed
214,215,NCT00644059,Phase 3,"Influenza, Human",4902,Completed
215,216,NCT01908517,Not Applicable,Patient Compliance,522,Completed
216,217,NCT01843621,Phase 1|Phase 2,Dengue,7,Completed
217,218,NCT04077424,Phase 4,Flu Vaccine,10,Completed
218,219,NCT01551810,Phase 3,Influenza,1200,Completed
219,220,NCT05801978,Phase 4,Vaccine Response,60,Recruiting
220,221,NCT04998344,Phase 4,Influenza Viral Infections,3800,"Active, not recruiting"
221,222,NCT00645411,Phase 2|Phase 3,Influenza,3604,Completed
222,223,NCT00999739,Phase 3,Pneumococcal Vaccines|HIV|HIV Infections,220,Unknown status
223,224,NCT05715918,Phase 3,Vaccine,300,"Active, not recruiting"
224,225,NCT05091307,Phase 3,COVID-19 Prevention,861,Completed
225,226,NCT04469569,Not Applicable,Papillomavirus Vaccines,5196,Recruiting
226,227,NCT00310804,Phase 3,Influenza,1200,Completed
227,228,NCT03205358,Phase 2,Meningitis|Meningococcal Meningitis|Meningococcal Infections,188,Completed
228,229,NCT02603055,Phase 1,Hepatitis E,60,Completed
229,230,NCT04811391,,Covid19,1500,Unknown status
230,231,NCT05929053,Not Applicable,Unrecognized Condition,74,Not yet recruiting
231,232,NCT05475379,Phase 1|Phase 2,Typhoid,630,Recruiting
232,233,NCT05401305,Phase 1,Haemophilus Influenzae Infection|Vaccines,60,Completed
233,234,NCT00366678,Phase 3,"Vaccines, Pneumococcal",613,Completed
234,235,NCT01712984,Phase 3,Influenza,3360,Completed
235,236,NCT02960815,Phase 2,Influenza Vaccine,70,Completed
236,237,NCT04691947,Phase 1,COVID-19 Vaccine,44,Completed
237,238,NCT03395106,Not Applicable,Vaccine Hesitancy,883,Completed
238,239,NCT00978120,Phase 2,H1N1 Influenza Virus,390,Completed
239,240,NCT01776541,Phase 2,Pandemic H5N1 Influenza,979,Completed
240,241,NCT04235257,Phase 4,HPV Infection|HPV Vaccine,40,"Active, not recruiting"
241,242,NCT00310713,Phase 4,Prevention of Meningococcal Infection,33,Completed
242,243,NCT04540653,Phase 4,Vaccine Response Impaired|Hepatitis B|Aging,240,Unknown status
243,244,NCT01591837,Phase 4,"Influenza, Human",120,Completed
244,245,NCT02547792,Phase 1,Seasonal Influenza B,54,Completed
245,246,NCT05414786,Phase 1,HIV-1-infection,18,"Active, not recruiting"
246,247,NCT04881396,,COVID-19 Vaccines|Hemodialysis Complication,99,Completed
247,248,NCT05070494,Phase 4,ESRD|Influenza Vaccine|Seroprotection,175,Unknown status
248,249,NCT00919178,Phase 1,Dengue Shock Syndrome|Dengue Hemorrhagic Fever,70,Completed
249,250,NCT04706143,,COVID-19 Vaccines,100,Unknown status
250,251,NCT00242424,Phase 2|Phase 3,Inactivated Influenza Vaccine,1375,Completed
251,252,NCT03330171,Phase 4,Measles|Varicella|Hepatitis A,278,Unknown status
252,253,NCT01859325,Phase 1,HIV|Therapeutic Vaccine,33,Completed
253,254,NCT00727636,Not Applicable,Inflammatory Bowel Disease,53,Completed
254,255,NCT05326152,Phase 1|Phase 2,Intralesional Versus Intramuscular Hepatitis B Vaccine for Multiple Common Warts,75,Completed
255,256,NCT01691326,Phase 4,Influenza,60,Completed
256,257,NCT03581734,Phase 3,Vaccine Reaction,579,Recruiting
257,258,NCT04951323,Phase 3,Coronavirus Disease 2019 (Covid19)|Hematopoietic Neoplasms,50,Recruiting
258,259,NCT01373281,Phase 3,Dengue|Dengue Fever|Dengue Hemorrhagic Fever,10275,Completed
259,260,NCT01349647,Phase 1,Lung Cancer,21,Completed
260,261,NCT00674583,Phase 3,"Infections, Meningococcal",414,Completed
261,262,NCT05432141,Phase 4,Poliomyelitis,3200,Completed
262,263,NCT01258062,Phase 1,Phase 1 Safety Study of GelVac Nasal Powder H5N1 Influenza Vaccine,7,Completed
263,264,NCT03042182,Phase 1|Phase 2,Cholangiocarcinoma,20,Unknown status
264,265,NCT02956421,Phase 2,Rabies,126,Completed
265,266,NCT01027351,Phase 2,Meningococcal Disease,163,Completed
266,267,NCT00439660,Phase 1|Phase 2,Diarrhea,540,Completed
267,268,NCT04751721,Not Applicable,Covid-19 Vaccine,20,Unknown status
268,269,NCT01412801,Phase 2,Streptococcal Infections|Gram-Positive Bacterial Infections|Bacterial Infections,270,Completed
269,270,NCT01079273,Phase 4,Influenza,7,Completed
270,271,NCT00645346,Phase 1,Invasive Group B Streptococcus (GBS) Disease,130,Completed
271,272,NCT06065176,Phase 4,COVID-19|Vaccine-Preventable Diseases|SARS CoV 2 Infection|Upper Respiratory Tract Infection|Upper Respiratory Disease,1500,Recruiting
272,273,NCT02258334,Phase 4,Influenza,208,Completed
273,274,NCT01013675,Phase 2,Influenza Vaccines,622,Completed
274,275,NCT04531657,,Influenza,79,Completed
275,276,NCT03867643,,Hepatitis B Vaccine Adverse Reaction,80,Recruiting
276,277,NCT05787015,Not Applicable,COVID-19|Vaccine Hesitancy,600,Recruiting
277,278,NCT01334047,Phase 1|Phase 2,Recurrent Epithelial Ovarian Cancer,5,Terminated
278,279,NCT00722098,Phase 2,Malignant Melanoma Stage IV,9,Terminated
279,280,NCT01026038,Phase 3,13-valent Pneumococcal Vaccine|Immunization|Safety|Antibody Response,263,Completed
280,281,NCT00519064,Phase 3,Influenza Disease,361,Completed
281,282,NCT00464672,Phase 3,Influenza,1893,Completed
282,283,NCT03756246,Phase 4,Depression|Healthy,75,Unknown status
283,284,NCT00329901,Phase 3,Meningococcal Disease|Meningococcal Meningitis,1072,Completed
284,285,NCT01103687,Phase 1,HIV Infections,24,Completed
285,286,NCT02075515,Phase 3,Herpes Zoster|Herpes Zoster Vaccine,651,Completed
286,287,NCT00501137,Phase 3,Cervical Cancer|Genital Warts,830,Completed
287,288,NCT01453348,Phase 3,Meningococcal Disease|Meningococcal Meningitis|Hepatitis A|Hepatitis B,252,Completed
288,289,NCT04928911,,Vaccine Adverse Reaction,1176,Completed
289,290,NCT02992977,Phase 1,Advanced Cancer,3,Terminated
290,291,NCT05046548,Phase 1|Phase 2,Coronavirus Infections|Vaccine,400,Completed
291,292,NCT01483274,Phase 1,Acute Myelogenous Leukemia,0,Withdrawn
292,293,NCT02718469,Phase 1,Ebola Virus Disease,38,Completed
293,294,NCT05212610,Phase 4,COVID-19|Corona Virus Infection,200,Recruiting
294,295,NCT01945268,Phase 4,Heart Failure,107,Completed
295,296,NCT01374516,Phase 3,Dengue Fever|Dengue Hemorrhagic Fever|Dengue,20869,Completed
296,297,NCT03303976,Phase 1,"Pneumococcal Pneumonia|Pneumonia, Bacterial",72,Completed
297,298,NCT01023711,Not Applicable,Influenza,107,Completed
298,299,NCT05178264,,Vaccine Adverse Reaction,580,Completed
299,300,NCT01155037,Phase 2,HIV Infection,450,Completed
300,301,NCT01164553,Phase 1,Influenza,243,Completed
301,302,NCT00943631,Phase 2,Influenza,406,Completed
302,303,NCT00678652,Phase 1,"Meningococcal Infection, Group B",36,Completed
303,304,NCT04711265,,HPV Vaccine|HPV Infection|HIV-1-infection,176,Completed
304,305,NCT01119157,Phase 4,Healthy Volunteers,85,Unknown status
305,306,NCT00925288,Phase 4,Human Papillomavirus Infection,200,Completed
306,307,NCT02133469,Not Applicable,Streptococcal Pneumonia|Nasopharyngeal Diseases|Vaccination Adverse Event,3281,Completed
307,308,NCT02212106,Phase 4,"Influenza, Human",402,Completed
308,309,NCT00389532,Phase 4,Influenza,116,Completed
309,310,NCT00414050,Phase 3,Hepatitis B,1718,Completed
310,311,NCT04364399,Phase 4,Mumps,920,Completed
311,312,NCT04529538,Phase 1,Poliomyelitis,205,Completed
312,313,NCT01808456,Phase 4,"Influenza, Human|Transplantation Infection",62,Completed
313,314,NCT02049489,Phase 1,Glioblastoma Multiforme,20,Completed
314,315,NCT01640327,Phase 3,Human|Influenza,126,Completed
315,316,NCT05986981,Phase 2,"Solid Tumor, Adult",20,Not yet recruiting
316,317,NCT01162122,Phase 3,Influenza,7109,Completed
317,318,NCT05575830,Phase 4,RZV Vaccine (Shingrix ®),225,Recruiting
318,319,NCT01830283,Phase 4,Varicella,50000,Unknown status
319,320,NCT01273233,Phase 1,"Infection; Viral, Enterovirus",36,Completed
320,321,NCT01926860,Phase 4,Measurement of Immune Response to Prevenar13|Measurement of Immune Response to Hepatitis A,300,Unknown status
321,322,NCT02819115,,Influenza,63,Completed
322,323,NCT00561184,Phase 2,Avian Influenza,47,Completed
323,324,NCT03036930,Phase 2,Human Papillomavirus Infection,180,"Active, not recruiting"
324,325,NCT01535794,,HPV Vaccine Attitudes|HPV Vaccine Intention,2000,Completed
325,326,NCT01422512,Phase 3,Influenza,126,Completed
326,327,NCT01346592,Phase 3,Influenza Disease,6104,Completed
327,328,NCT02018458,Phase 1|Phase 2,Breast Cancer,10,Completed
328,329,NCT03391193,Phase 3,Influenza,301,Completed
329,330,NCT02955797,Phase 3,Meningitis|Meningococcal Meningitis|Meningococcal Infections,918,Completed
330,331,NCT03263403,Phase 2|Phase 3,Meningococcal Vaccine,88,Completed
331,332,NCT05863585,Phase 1,Hiv,14,Not yet recruiting
332,333,NCT05085145,Phase 4,People Living With HIV|COVID-19|Vaccine,200,Unknown status
333,334,NCT02555072,Phase 4,Yellow Fever Vaccine|Immunity,4761,"Active, not recruiting"
334,335,NCT01986322,Phase 2,Healthy,220,Completed
335,336,NCT00323557,Phase 2,Leukemia,39,Completed
336,337,NCT01636102,Phase 2,Human Influenza,126,Completed
337,338,NCT01668745,Phase 4,Measles Vaccine,4050,Unknown status
338,339,NCT05111353,Phase 1,Pancreas Cancer|Pancreatic Cancer|Cancer of the Pancreas,30,Recruiting
339,340,NCT02806804,Phase 3,Quadrivalent Influenza Virus Vaccine,2400,Unknown status
340,341,NCT00366899,Phase 3,"Vaccines, Pneumococcal",605,Completed
341,342,NCT04977479,Phase 2,Systemic Allergic Reaction,20,Completed
342,343,NCT06091410,Phase 4,COVID-19|Influenza|Vaccine Reaction|Contaminant Injected,60,Recruiting
343,344,NCT00744263,Phase 4,"Pneumonia, Pneumococcal|Pneumococcal Infections|13-valent Pneumococcal Vaccine",84496,Completed
344,345,NCT03038802,Phase 1|Phase 2,Chronic Hepatitis b,40,Not yet recruiting
345,346,NCT01215734,Phase 1,Adult Stem Cell Hematopoetic Transplant,44,Completed
346,347,NCT05060861,,ChAdOx1 nCoV-19 Vaccine,2000,Unknown status
347,348,NCT01096225,,Human Influenza,20,Unknown status
348,349,NCT01512784,Phase 3,HPV|HIV,100,Unknown status
349,350,NCT00854789,Phase 1,Breast Cancer,95,Completed
350,351,NCT05916261,Early Phase 1,Advanced Pancreatic Cancer,54,Recruiting
351,352,NCT01445743,Phase 2,Pregnancy,204,Completed
352,353,NCT00893906,Phase 4,Influenza,10000,Completed
353,354,NCT04036526,Phase 1|Phase 2,Whooping Cough,50,Unknown status
354,355,NCT05518500,Phase 4,Aging|Influenza Vaccine|Dendritic Cell|Vaccine Response,66,Recruiting
355,356,NCT05234333,,Vaccine Adverse Reaction,1534706,Completed
356,357,NCT00995813,Phase 4,Intestinal Failure|Rotavirus Vaccines,15,Completed
357,358,NCT03430388,Not Applicable,Systemic Lupus|Rheumatoid Arthritis|Spondyloarthritis|Inflammatory Myopathy|Systemic Sclerosis|Mixed Connective Tissue Disease|Takayasu Arteritis|Granulomatosis With Polyangiitis|Sjogren's Syndrome|Juvenile Idiopathic Arthritis|Juvenile Dermatomyositis,600,Completed
358,359,NCT01091298,Phase 1,Rotavirus Gastroenteritis,20,Completed
359,360,NCT00649883,Phase 2,Influenza,360,Completed
360,361,NCT01510366,Phase 3,Poliomyelitis,1200,Completed
361,362,NCT05059821,Phase 1,Hepatocellular Carcinoma,10,Recruiting
362,363,NCT01946438,Phase 4,Influenza,208,Completed
363,364,NCT03475056,Phase 1,Marburg Virus Disease,40,Completed
364,365,NCT04818736,Phase 4,Vaccine Preventable Disease,0,Withdrawn
365,366,NCT00842530,Phase 2,Dengue Virus|Dengue Fever|Dengue Hemorrhagic Fever|Dengue Diseases,4002,Completed
366,367,NCT00366340,Phase 3,"Vaccines, Pneumococcal",604,Completed
367,368,NCT05916248,Phase 1,Advanced Solid Tumor,60,Recruiting
368,369,NCT01997632,Phase 1,Poliomyelitis,120,Completed
369,370,NCT02851459,Not Applicable,Childhood Vaccinations,850,Completed
370,371,NCT01205581,Phase 2,HIV|Cancer,85,Completed
371,372,NCT01273922,Phase 1,Staphylococcal Infections|Candidiasis,40,Completed
372,373,NCT01676402,Phase 1,Influenza,316,Completed
373,374,NCT00676091,Phase 3,"Vaccines, Pneumococcal Conjugate Vaccine",354,Completed
374,375,NCT03654677,Phase 3,Hepatitis A Vaccine,253,Completed
375,376,NCT05788510,,Pneumococcal Vaccine,106,Completed
376,377,NCT00522067,Phase 2,Influenza Disease,52,Completed
377,378,NCT03509051,Not Applicable,Hematopoietic Stem Cell Transplant|Meningococcal Vaccine,40,Completed
378,379,NCT02869672,Phase 3,ACYW135 Meningococcal Polysaccharide Vaccine,1200,Unknown status
379,380,NCT05226429,Phase 1|Phase 2,COVID-19 Pandemic|Vaccine Reaction,495,Recruiting
380,381,NCT01129453,Phase 1,Salmonella,51,Completed
381,382,NCT01258595,Phase 2,Influenza,300,Completed
382,383,NCT03702231,Phase 2,Safety and Tolerability|Compare SHINGRIX Vaccine Response Rates|Chronic Lymphocytic Leukemia (CLL)|Small Lymphocytic Lymphoma (SLL),116,Completed
383,384,NCT04809948,,COVID 19 Vaccine,800,Unknown status
384,385,NCT01493154,Phase 1,Head and Neck Cancer,2,Terminated
385,386,NCT01367158,Phase 2,Meningococcal Disease|Meningococcal Meningitis,440,Completed
386,387,NCT01272180,Phase 2,Invasive Meningococcal Disease,484,Completed
387,388,NCT00262002,Phase 2,Prevention of Meningococcal Disease,601,Completed
388,389,NCT04871165,,Hematologic Neoplasms|COVID-19 Vaccines,3270,Recruiting
389,390,NCT03933098,Phase 3,Typhoid,1800,Unknown status
390,391,NCT00311441,Phase 4,"Encephalitis, Tick-Borne",300,Completed
391,392,NCT00633074,Phase 2,Influenza,720,Completed
392,393,NCT00938392,Phase 3,Influenza,726,Completed
393,394,NCT02035696,Phase 1|Phase 2,Influenza,671,Completed
394,395,NCT03001986,Phase 4,"Hand, Foot and Mouth Disease (HFMD)",40724,Completed
395,396,NCT03591770,Phase 4,Inflammatory Bowel Diseases,100,Recruiting
396,397,NCT01696422,Phase 2,Dengue,300,Unknown status
397,398,NCT04941144,,Coronavirus Disease (COVID-19),8538,Completed
398,399,NCT05918939,Early Phase 1,COVID-19 Pandemic|COVID-19 Vaccines,350,Recruiting
399,400,NCT01857297,Phase 4,"Influenza, Human",120,Completed
400,401,NCT01989533,Phase 1,Vaccine Response,62,Completed
401,402,NCT00382187,Phase 2,Influenza,40,Completed
402,403,NCT05463419,Phase 2|Phase 3,Covid-19 Vaccine,5860,"Active, not recruiting"
403,404,NCT04041570,Phase 1,Ebola Virus,40,Completed
404,405,NCT02544698,Phase 1,Pneumococcal 13-valent Conjugate Vaccine,120,Unknown status
405,406,NCT00862810,Phase 4,Cervical Cancer|Genital Warts,72,Completed
406,407,NCT02894840,Phase 1|Phase 2,Influenza,340,Completed
407,408,NCT02628054,Not Applicable,Typhoid Vaccine on Sleep,16,Completed
408,409,NCT04537156,Phase 3,Cervical Intraepithelial Neoplasia|Cervical Cancer|Condylomata Acuminata,9327,"Active, not recruiting"
409,410,NCT05096832,Phase 3,COVID-19 Pandemic,10381,Completed
410,411,NCT03914768,Phase 1,Diffuse Intrinsic Pontine Glioma or Glioblastoma,10,Unknown status
411,412,NCT01360970,Phase 2,Response to Hepatitis A Vaccine,68,Completed
412,413,NCT00661713,Phase 2|Phase 3,Meningococcal Disease,1631,Completed
413,414,NCT00637195,Phase 3,"Infections, Papillomavirus|Papillomavirus Vaccines",152,Completed
414,415,NCT06074237,Not Applicable,Vaccine Refusal|Vaccine-Preventable Diseases|Physician-Patient Relations,112,Not yet recruiting
415,416,NCT01977170,Phase 1,Healthy,25,Completed
416,417,NCT00746798,Phase 2,West Nile Fever,479,Completed
417,418,NCT00474487,Phase 3,Meningococcal Meningitis|Meningococcal Infections,2831,Completed
418,419,NCT02762851,Phase 4,Heart Failure|Influenza,5000,Unknown status
419,420,NCT05228613,Phase 1,COVID-19,175,Completed
420,421,NCT00158665,Not Applicable,Influenza,280,Completed
421,422,NCT01811823,Phase 4,Influenza|HIV|Tuberculosis,301,Completed
422,423,NCT06156228,Not Applicable,Vaccine Hesitancy,200,Not yet recruiting
423,424,NCT01766921,Phase 2,Pandemic H5N1 Influenza,1393,Completed
424,425,NCT01273246,Phase 1,"Hand-foot-mouth Disease|Infection; Viral, Enterovirus",132,Completed
425,426,NCT00962624,Phase 2,"Meningococcal Meningitis, Serogroup A|Meningococcal Meningitis, Serogroup B|Meningococcal Meningitis, Serogroup C|Meningococcal Meningitis, Serogroup Y|Meningococcal Meningitis, Serogroup W",38,Completed
426,427,NCT02233816,Phase 2,Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections,300,Completed
427,428,NCT02275039,Phase 1,Recurrent Ovarian Epithelial Cancer|Recurrent Fallopian Tube Carcinoma|Recurrent Primary Peritoneal Carcinoma,12,Completed
428,429,NCT01941056,Phase 1,"Cytomegalovirus Infection|Healthy, no Evidence of Disease",24,Completed
429,430,NCT04892888,,Coronavirus Disease (COVID-19),0,Withdrawn
430,431,NCT02433652,Phase 1,Dengue,24,Completed
431,432,NCT04072276,,Enterovirus 71 Human,227,Completed
432,433,NCT05017805,Not Applicable,Liver Disease Chronic,300,Recruiting
433,434,NCT04568811,Phase 1,Adenovirus Type-5 Vectored COVID-19 Vaccine,89,Completed
434,435,NCT05218070,Phase 1,COVID-19,45,Unknown status
435,436,NCT01629589,Phase 4,Tetanus|Diphtheria|Pertussis|Whooping Cough,423,Completed
436,437,NCT00944073,Phase 2,Influenza,583,Completed
437,438,NCT01047202,Phase 4,Influenza,310,Completed
438,439,NCT01616693,Phase 4,Immunity to Oral Rotavirus Vaccine|Immunity to Oral Polio Vaccine|Shedding of Oral Rotavirus Vaccine,620,Completed
439,440,NCT03735147,Phase 4,Influenza Vaccines,12,Completed
440,441,NCT02563093,Phase 4,Influenza,208,Completed
441,442,NCT01623232,Phase 1|Phase 2,Influenza Vaccines|Aged,0,Withdrawn
442,443,NCT04930185,Not Applicable,COVID-19 Vaccination,600,Unknown status
443,444,NCT01876212,Phase 2,Metastatic Melanoma,15,Completed
444,445,NCT02479230,Phase 1,Breast Cancer|Metastatic Breast Cancer,18,Completed
445,446,NCT01004653,Phase 4,Influenza,100,Completed
446,447,NCT00870987,Phase 1|Phase 2,Malaria,82,Completed
447,448,NCT01979406,Phase 1,Anthrax Infection,120,Completed
448,449,NCT01883518,Phase 1|Phase 2,"Sarcoma|Neoplasms, Connective and Soft Tissue",48,Unknown status
449,450,NCT00601835,Phase 4,Diphtheria|Tetanus,3651,Completed
450,451,NCT05507671,Phase 3,COVID-19,556,"Active, not recruiting"
451,452,NCT00980850,Phase 2,Influenza,1000,Completed
452,453,NCT00934245,Phase 4,Influenza,4598,Completed
453,454,NCT00449670,Phase 3,Influenza|Influenza Vaccines,1206,Completed
454,455,NCT05067894,Phase 1,Covid19,54,Completed
455,456,NCT06062056,Not Applicable,Vaccine Hesitancy,6000,Enrolling by invitation
456,457,NCT06162494,Phase 4,Varicella Zoster,120,Not yet recruiting
457,458,NCT05315830,Phase 1,Adenocarcinoma - GEJ|Adenocarcinoma of the Stomach,10,Recruiting
458,459,NCT01430819,Phase 4,Influenza,300,Completed
459,460,NCT04693689,Not Applicable,Trust,35180,Completed
460,461,NCT03813940,Phase 1,Condylomata Acuminata|Cervical Cancer,24,Completed
461,462,NCT00311415,Phase 3,Prevention of Meningococcal Infection,257,Completed
462,463,NCT00317473,Phase 1,Plasmodium Falciparum Malaria,135,Completed
463,464,NCT00914771,Phase 2,Pandemic H5N1 Influenza,722,Completed
464,465,NCT01203319,Phase 2|Phase 3,Hepatitis b,1091,Completed
465,466,NCT05996549,Phase 4,Influenza Vaccine|Cost-Effectiveness|Vaccination,2567,Recruiting
466,467,NCT02313740,,Influenza,120,Completed
467,468,NCT05154383,Phase 4,Vaccine Reaction,60,Completed
468,469,NCT04760704,,Covid19 Vaccine,250,"Active, not recruiting"
469,470,NCT04567069,Phase 1|Phase 2,Gastric Cancer,45,Unknown status
470,471,NCT05362682,,Sars-CoV-2 Infection,3000,Recruiting
471,472,NCT01977196,Phase 1,Healthy,30,Completed
472,473,NCT04368429,Phase 3,Meningococcal Immunisation (Healthy Volunteers),360,Completed
473,474,NCT01758185,Phase 4,Healthy,3308,Completed
474,475,NCT05648513,Not Applicable,Vaccine Refusal|Pregnancy Related|Motivation,52,Not yet recruiting
475,476,NCT01424644,Phase 4,Meningococcal Meningitis,801,Completed
476,477,NCT00258817,Phase 4,Influenza,30,Completed
477,478,NCT02640989,Phase 4,Influenza,292,Completed
478,479,NCT02981836,Phase 3,Varicella,5997,Completed
479,480,NCT02158364,,Measles/Rubella,3331,Completed
480,481,NCT04094883,Phase 4,Neisseria Gonorrhoeae Infection,11,Completed
481,482,NCT01073306,Phase 1,Dengue Virus,18,Completed
482,483,NCT02151773,,Measles/Rubella,3493,Completed
483,484,NCT04461379,Phase 3,BCG|COVID-19|SARS-CoV2|Corona Virus Infection,908,Unknown status
484,485,NCT01663636,,Adherence to Vaccination Schedules,321,Completed
485,486,NCT00857311,Phase 1,Hepatitis C,17,Completed
486,487,NCT00574886,Not Applicable,Lymphoma,2,Completed
487,488,NCT00828828,,Pulmonary Sarcoidosis,49,Completed
488,489,NCT02602652,Not Applicable,Japanese Encephalitis,50,Completed
489,490,NCT01250249,Phase 3,Healthy,120,Completed
490,491,NCT00332956,Phase 2,Healthy Volunteers,400,Completed
491,492,NCT01254175,Phase 1,"Parainfluenza Virus 3, Human",28,Completed
492,493,NCT02461758,Phase 4,Inflammatory Bowel Disease (IBD),81,Completed
493,494,NCT01266707,Phase 1,Hepatocellular Carcinoma,9,Unknown status
494,495,NCT01422200,Phase 4,Duchenne Muscular Dystrophy|Spinal Muscular Atrophy|Congenital Muscular Dystrophy,22,Completed
495,496,NCT01048190,Phase 1,Poliomyelitis,130,Completed
496,497,NCT03739112,Phase 3,Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections,12794,Completed
497,498,NCT04780035,Phase 3,COVID-19,3000,Completed
498,499,NCT04730895,Phase 1|Phase 2,Covid19 Vaccine,360,Unknown status
499,500,NCT02153866,Phase 4,Rotavirus,2800,Unknown status
500,501,NCT02908269,Phase 4,Influenza,180,Completed
501,502,NCT01064141,Phase 2,Dengue Fever|Dengue Hemorrhagic Fever,210,Completed
502,503,NCT00579345,Phase 3,Influenza,1522,Completed
503,504,NCT00310648,Phase 3,Influenza,600,Completed
504,505,NCT02808416,Phase 1,Brain Cancer|Neoplasm Metastases,10,Completed
505,506,NCT01640691,Phase 1|Phase 2,Pandemic Influenza,39,Completed
506,507,NCT04940130,Phase 2,"Malaria|Malaria,Falciparum",290,Completed
507,508,NCT05012943,Phase 2|Phase 3,COVID-19 Vaccines,19494,Completed
508,509,NCT02264236,Phase 1|Phase 2,Lung Neoplasms,0,Withdrawn
509,510,NCT01264445,Phase 1,HIV Infections,147,Completed
510,511,NCT01854632,Phase 3,Influenza,1761,Completed
511,512,NCT01982331,Phase 1,Influenza,38,Completed
512,513,NCT01436422,Phase 1,Dengue,112,Completed
513,514,NCT03104075,Phase 4,Pneumonia|Aging,40,Completed
514,515,NCT03748524,Early Phase 1,"Immunity, Cellular",11,Unknown status
515,516,NCT01396512,Phase 3,Japanese Encephalitis|Japanese Encephalitis Virus Disease,274,Completed
516,517,NCT04751695,Not Applicable,Covid-19 Vaccine,20,Unknown status
517,518,NCT01658800,Phase 1,Influenza,275,Completed
518,519,NCT00309634,Phase 1,Influenza,400,Completed
519,520,NCT00254826,Phase 1,Viremia,80,Completed
520,521,NCT00474539,Phase 3,"Vaccines, Pneumococcal",449,Completed
521,522,NCT05386355,Not Applicable,COVID-19 Vaccines|Telemedicine|Vaccine Hesitancy|Pediatric ALL,727,"Active, not recruiting"
522,523,NCT05752201,Phase 2|Phase 3,COVID-19 Vaccine,2014,Completed
523,524,NCT04713163,,Covid19,200,Unknown status
524,525,NCT04142242,Phase 3,Meningococcal Infection (Healthy Volunteers),471,Completed
525,526,NCT01177202,Phase 1,H1N1 Flu,80,Completed
526,527,NCT02993757,Phase 3,Dengue Fever|Dengue Hemorrhagic Fever|Human Papillomavirus Disease,528,Completed
527,528,NCT04691908,Phase 3,Covid19|SARS-CoV Infection|Vaccine Adverse Reaction,3000,Completed
528,529,NCT03301051,Phase 3,Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections|Influenza,10160,Completed
529,530,NCT05107375,Phase 3,Coronavirus Disease 2019,299,Completed
530,531,NCT00380367,Phase 3,Papillomavirus Infections,110,Completed
531,532,NCT04838080,Phase 1,COVID-19 Vaccine,38,Unknown status
532,533,NCT01444482,Phase 1,Influenza,110,Unknown status
533,534,NCT01732627,Phase 2,Meningitis|Meningococcal Meningitis|Meningococcal Infections|Invasive Meningococcal Disease,301,Completed
534,535,NCT00607178,Phase 2|Phase 3,Coronary Artery Diseases|Myocardial Infarction|Stable Angina,300,Completed
535,536,NCT01720277,Phase 4,Influenza,2957,Completed
536,537,NCT05056402,Phase 3,Cervical Cancer|Condylomata Acuminata,1382,"Active, not recruiting"
537,538,NCT01000311,Phase 3,Meningococcal Disease,529,Completed
538,539,NCT00866476,Phase 2,Shigella,20,Terminated
539,540,NCT03460002,Phase 4,Measles Vaccination|Oral Polio Vaccine|Non-specific/Heterologous Effects of Vaccines|Mortality|Morbidity|Children,28000,Unknown status
540,541,NCT01772901,Not Applicable,Influenza|Infectious Disease|Pregnancy,321,Completed
541,542,NCT01368796,Phase 4,Influenza Vaccine,953,Completed
542,543,NCT02193347,Phase 1,"Brain Cancer|Brain Neoplasm, Primary|Brain Neoplasms, Recurrent|Brain Tumor|Cancer of the Brain",24,Completed
543,544,NCT00097396,Phase 1,Pneumonic Plague|Preventive Therapy,40,Completed
544,545,NCT02553343,Phase 2,Influenza,792,Completed
545,546,NCT05966090,Phase 3,Respiratory Syncytial Viruses|Respiratory Syncytial Virus Infections,530,"Active, not recruiting"
546,547,NCT03694808,Phase 4,Flu,478,Completed
547,548,NCT05582564,Not Applicable,Vaccine Hesitancy,1068,Completed
548,549,NCT00559975,Phase 1,Influenza Infection,60,Completed
549,550,NCT01666262,Phase 1|Phase 2,Healthy,363,Completed
550,551,NCT02109354,Phase 1,HIV Infection,202,Completed
551,552,NCT00343889,Phase 3,Diphtheria|Tetanus|Pertussis|Hepatitis B|Haemophilus Infections,379,Completed
552,553,NCT00684294,Phase 1,"Carcinoma, Advanced Metastatic",46,Terminated
553,554,NCT02999828,Phase 4,Safety of Inactivated EV71 Vaccine|Immunization of Inactivated EV71 Vaccine,20770,Unknown status
554,555,NCT01857206,Phase 3,Influenza|Fever,2055,Completed
555,556,NCT06195384,Phase 1,"Solid Tumor, Adult",30,Not yet recruiting
556,557,NCT05236491,Phase 2|Phase 3,Rheumatoid Arthritis|Autoimmune Rheumatologic Disease|Systemic Lupus Erythematosus|Systemic Vasculitis|Systemic Sclerosis|Scleroderma|Undifferentiated Connective Tissue Diseases|Overlap Connective Tissue Disease|Immunosuppression,287,Recruiting
557,558,NCT00885105,Phase 3,Influenza,242,Completed
558,559,NCT00101166,Phase 2,Melanoma (Skin),43,Completed
559,560,NCT03384914,Phase 2,"Breast Cancer Female|Breast Cancer, Male|Breast Cancer Stage I|Breast Cancer Stage II|Breast Cancer Stage III|Residual Disease|HER2-positive Breast Cancer|HER2 Positive Breast Carcinoma",119,"Active, not recruiting"
560,561,NCT02429583,Phase 4,Hepatitis C Infection,24,Terminated
561,562,NCT02286895,Phase 4,Diarrhea Rotavirus,600,Completed
562,563,NCT01635816,Phase 4,Healthy Infants,1000,Completed
563,564,NCT02456077,Not Applicable,HPV Immunization Status,93582,Completed
564,565,NCT03165617,Phase 3,"Influenza, Human",4514,Completed
565,566,NCT05599516,Phase 3,COVID-19|Coronavirus Infections,16000,Recruiting
566,567,NCT01246999,Phase 4,Influenza,34,Completed
567,568,NCT01000831,Phase 4,Influenza,167,Completed
568,569,NCT01968083,Phase 1,Respiratory Syncytial Virus Infections,51,Completed
569,570,NCT01001650,Phase 1,Plasmodium Falciparum,80,Completed
570,571,NCT00482027,Phase 1,HIV Infection,80,Completed
571,572,NCT01551823,Phase 3,Influenza,1200,Completed
572,573,NCT01446289,Phase 2,Streptococcal Infection|Gram-positive Bacterial Infection|Bacterial Infection,86,Completed
573,574,NCT01341808,Phase 4,Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis|Hepatitis A,493,Completed
574,575,NCT02109484,Phase 1|Phase 2,Evaluation of a Rotavirus Vaccine,204,Completed
575,576,NCT05482295,Phase 3,Vaccine Reaction|Vaccine Adverse Reaction,540,Not yet recruiting
576,577,NCT03701061,Phase 4,Influenza A Subtype H5N1 Infection,12,Completed
577,578,NCT03101111,Phase 2,Chikungunya,34,Completed
578,579,NCT00946179,Phase 2,Influenza,130,Completed
579,580,NCT05470582,Phase 3,"Influenza, Human|Vaccination; Infection|Vaccines",1066,Completed
580,581,NCT02425098,Phase 2,Dengue Fever,351,Completed
581,582,NCT04936685,Phase 3,Meningococcal Immunisation (Healthy Volunteers),166,"Active, not recruiting"
582,583,NCT01147081,Phase 3,Seasonal Influenza,142,Completed
583,584,NCT05724472,Phase 1,Ebola Sudan Virus Disease,36,"Active, not recruiting"
584,585,NCT00125008,Phase 4,Typhoid|Paratyphoid Fever,37673,Completed
585,586,NCT00845429,Phase 2,Influenza|Orthomyxoviruses|Myxovirus Infection,729,Completed
586,587,NCT05189548,Phase 1|Phase 2,Safety、Immunogenicity,72,Unknown status
587,588,NCT00984945,Phase 1,Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections,48,Completed
588,589,NCT01508247,Phase 3,"Hand, Foot and Mouth Disease|Herpangina|Other EV71-associated Diseases",10245,Completed
589,590,NCT04546425,Phase 3,Pneumococcal Disease,1258,Completed
590,591,NCT06195293,Phase 1,"Solid Tumor, Adult",30,Not yet recruiting
591,592,NCT01640652,Phase 1,Serogroup B Meningococcal Disease,52,Completed
592,593,NCT01906190,Not Applicable,"Influenza, Human|Immunisation Reaction",207,Completed
593,594,NCT01014845,Phase 3,Hepatitis E,112604,Completed
594,595,NCT01782300,Phase 1,Dengue,48,Completed
595,596,NCT01008137,Phase 4,Influenza,150,Completed
596,597,NCT01180699,Not Applicable,Influenza Vaccine,229,Completed
597,598,NCT01561989,Not Applicable,"Healthy, no Evidence of Disease",11,Terminated
598,599,NCT05745987,Phase 4,Monkeypox,1560,Not yet recruiting
599,600,NCT01007201,Not Applicable,Influenza,183,Completed
600,601,NCT00205270,,Influenza,126,Completed
601,602,NCT01209780,Phase 3,Seasonal Influenza,3116,Completed
602,603,NCT00373958,Phase 3,"Vaccines, Pneumococcal",666,Completed
603,604,NCT00269672,Phase 2,"Vaccines, Pneumococcal Conjugate Vaccine",915,Completed
604,605,NCT00488683,Phase 2,Meningococcal Disease,216,Completed
605,606,NCT02111070,Phase 1,Healthy,44,Completed
606,607,NCT04566276,Phase 1|Phase 2,COVID-19 Vaccine|Safety Issues,192,Completed
607,608,NCT00893997,Phase 2,Leukemia|Myelodysplastic Syndrome,12,Terminated
608,609,NCT00992017,Phase 2,HIV Infections|H1N1 Influenza Virus,130,Completed
609,610,NCT04723602,Phase 1,Ebola Virus Disease|Marburg Virus Disease,32,Completed
610,611,NCT00444457,Phase 3,"Vaccines, Pneumococcal",1712,Completed
611,612,NCT01461096,Phase 3,HIV Infections,575,Completed
612,613,NCT00616421,Phase 3,Meningococcal Infections,2907,Completed
613,614,NCT04953130,Phase 4,HPV Infection|Vaccine Preventable Disease,10400,"Active, not recruiting"
614,615,NCT03894969,Phase 2,Respiratory Disorders,541,Completed
615,616,NCT05879107,Phase 3,Respiratory Syncytial Virus Infections,1113,"Active, not recruiting"
616,617,NCT01266083,Phase 2,Acute Myeloid Leukemia|Acute Lymphoblastic Leukemia,22,Completed
617,618,NCT05213455,,Vaccine Reaction,150,"Active, not recruiting"
618,619,NCT00970177,Phase 3,Pandemic Influenza,812,Completed
619,620,NCT02514018,Phase 4,Healthy,45,Unknown status
620,621,NCT02935192,Phase 3,Influenza,480,Completed
621,622,NCT06136832,Not Applicable,"Pneumonia, Pneumococcal|Vaccine",100,Not yet recruiting
622,623,NCT02186626,Phase 1,West Nile Virus,28,Completed
623,624,NCT02152709,Phase 3,Hepatitis B,1537,Completed
624,625,NCT04382326,Phase 3,Pneumococcal Disease,1997,Completed
625,626,NCT00130793,Phase 3,Herpes Zoster,368,Completed
626,627,NCT00316628,Phase 2,Influenza,50,Completed
627,628,NCT00714285,Phase 1,Influenza,420,Completed
628,629,NCT01003145,Not Applicable,Influenza,292,Completed
629,630,NCT00722774,Phase 1,Influenza|Virus Diseases,22,Completed
630,631,NCT04232943,Phase 1,Polio,87,Completed
631,632,NCT01092507,Phase 3,Encephalitis|Japanese Encephalitis,300,Completed
632,633,NCT02729168,Not Applicable,Rabies,120,Completed
633,634,NCT00391053,Phase 3,Orthomyxoviridae Infection|Influenza|Myxovirus Infection,3851,Completed
634,635,NCT03373669,Phase 4,Cholera|Vibrio Cholerae Infection,120,Completed
635,636,NCT00841399,Phase 1,Breast Cancer,100,Completed
636,637,NCT03908671,Not Applicable,Esophageal Cancer|Non Small Cell Lung Cancer,24,Recruiting
637,638,NCT04985760,Phase 1,HIV Infections,32,Recruiting
638,639,NCT03140774,,Ebola Virus Disease,126,Completed
639,640,NCT00537524,Phase 2,Prophylaxis of Avian Influenza,471,Completed
640,641,NCT05268185,Not Applicable,COVID-19|Vaccine Reaction|COVID-19 Pandemic,301,Completed
641,642,NCT03016884,Phase 4,Herpes Zoster,87,Unknown status
642,643,NCT05096260,Not Applicable,COVID-19 Vaccines|COVID-19 Pandemic,400,Recruiting
643,644,NCT05767138,,HPV|HPV-Related Cervical Carcinoma,301,Completed
644,645,NCT04533061,,Influenza,24,Completed
645,646,NCT00014131,Phase 1,Kidney Cancer,9,Terminated
646,647,NCT02326194,Phase 1,Ebola Virus Disease,120,Completed
647,648,NCT03540823,Phase 4,Systemic Lupus|Sjogren's Syndrome,300,Completed
648,649,NCT00808444,Phase 3,"Infections, Streptococcal",466,Completed
649,650,NCT02477995,Phase 3,Pertussis,1200,Completed
650,651,NCT00316615,Phase 2,Influenza Disease,100,Completed
651,652,NCT00310206,Phase 1,Influenza,100,Completed
652,653,NCT02154308,Phase 3,Healthy,787,Completed
653,654,NCT06100913,Phase 2,Ebola Virus Disease,30,Not yet recruiting
654,655,NCT03277703,Phase 2,Rheumatologic Disorder|Inflammatory Bowel Diseases|Immune Complex Diseases,30,Completed
655,656,NCT04162600,Phase 1,Rabies,18,"Active, not recruiting"
656,657,NCT03121339,Phase 1,Seasonal Influenza Preventative Vaccine Pharmacodynamics,8,Completed
657,658,NCT02255279,Phase 3,Influenza,287,Completed
658,659,NCT05457894,Phase 3,"Influenza, Human|Vaccination; Infection|Vaccines",207,Completed
659,660,NCT00922259,Phase 1,Influenza A,25,Completed
660,661,NCT01339845,Not Applicable,Cholera,240000,Completed
661,662,NCT05411471,Phase 2,COVID-19,221,Completed
662,663,NCT01933776,Phase 1,Diphtheria|Tetanus|Pertussis,40,Completed
663,664,NCT05734508,Phase 4,Monkeypox,1000,Recruiting
664,665,NCT05119855,Phase 3,Papillomavirus Infections|Coronavirus Disease (COVID-19),165,Completed
665,666,NCT04895007,,COVID-19 Vaccines,1500,Unknown status
666,667,NCT00944580,Phase 1,Neuroblastoma|Rhabdomyosarcoma|Osteogenic Sarcoma,0,Withdrawn
667,668,NCT02289794,Phase 1,E.Coli Infections,194,Completed
668,669,NCT04530786,,Influenza,100,Completed
669,670,NCT01097941,Phase 4,2009 H1N1 Influenza,0,Withdrawn
670,671,NCT01478347,Phase 3,Meningococcal Disease|Meningococcal Meningitis,18,Completed
671,672,NCT02657161,Phase 1,Rabies,37,Completed
672,673,NCT04111432,Phase 4,"Hand, Foot and Mouth Disease",372,Completed
673,674,NCT03199040,Phase 1,Triple Negative Breast Cancer|Triple Negative Breast Neoplasms|TNBC - Triple-Negative Breast Cancer|Triple-negative Breast Carcinoma,18,Terminated
674,675,NCT00388583,Phase 2,Orthomyxoviridae Infection|Influenza|Myxovirus Infection,817,Completed
675,676,NCT05037435,Phase 3,Rotavirus Infections|Rotavirus Vaccines,40,Completed
676,677,NCT01189656,Phase 2,Chronic Hepatitis B Patients With HBeAg-positive,33,Unknown status
677,678,NCT03300817,Phase 1,Lung Carcinoma,50,"Active, not recruiting"
678,679,NCT03654664,Phase 3,Hepatitis A Vaccine,119,Completed
679,680,NCT02263703,Phase 3,Autoimmune Disease|Juvenile Idiopathic Arthritis|Inflammatory Bowel Disease|Evidence of Liver Transplantation|Kidney Transplant Infection|Bone Marrow Transplant Infection,55,Completed
680,681,NCT05869201,Phase 2|Phase 3,"Influenza|Influenza, Human|Influenza Viral Infections|Vaccine Reaction|Vaccination; Infection",450,Completed
681,682,NCT00133445,Phase 2,Diphtheria|Hepatitis B|Poliomyelitis|Pertussis|Tetanus,5,Completed
682,683,NCT00626327,Phase 3,Meningococcal Infections,1630,Completed
683,684,NCT02092142,Phase 2,Q Fever,0,Withdrawn
684,685,NCT02569632,Phase 4,Meningococcal Infections,18,Completed
685,686,NCT00518180,Phase 3,Meningococcal Meningitis|Human Papillomavirus Infection|Pertussis|Tetanus,1620,Completed
686,687,NCT05215327,Phase 2,Immunization; Infection|Transplantation Infection|Influenza,270,Recruiting
687,688,NCT00572000,Not Applicable,Human Papillomavirus (HPV) Vaccine,222,Unknown status
688,689,NCT02038842,Phase 1|Phase 2,HIV Infection,92,Completed
689,690,NCT01827397,Phase 1,- HIV,24,Completed
690,691,NCT03743688,,"Influenza|Influenza, Human|Vaccine Reaction|Influenza A|Influenza Type B|Influenza A H1N1|Influenza A H3N2",10,Completed
691,692,NCT00699764,Phase 3,Herpes Simplex,2491,Completed
692,693,NCT00079820,Phase 1,Smallpox,110,Completed
693,694,NCT01609998,Phase 1,Influenza,75,Completed
694,695,NCT00584454,Phase 2,Q Fever,10,Completed
695,696,NCT05850364,Phase 3,Poliomyelitis|Polio,1440,Recruiting
696,697,NCT02002065,,Hepatitis A,332,Completed
697,698,NCT03931239,Not Applicable,Diphtheria|Tetanus|Pertussis|Hepatitis B|Haemophilus Influenzae Type B,222,Completed
698,699,NCT02963714,Phase 4,Hepatitis B Vaccine,352,Completed
699,700,NCT01522248,Not Applicable,Influenza Virus Vaccine,20,Completed
700,701,NCT04467541,Phase 1|Phase 2,Hand Foot & Mouth Disease,430,Completed
701,702,NCT05895110,Not Applicable,COVID-19,240,Completed
702,703,NCT06177249,Phase 3,Rabies Human,1956,Completed
703,704,NCT04944381,Not Applicable,SARS-CoV-2 Acute Respiratory Disease,112,Unknown status
704,705,NCT00807781,Phase 1,Metastatic Breast Cancer,15,Completed
705,706,NCT02274545,Phase 1,"Influenza A Virus, H7N9 Subtype",24,Completed
706,707,NCT00366548,Phase 3,"Vaccines, Pneumococcal",500,Completed
707,708,NCT01776554,Phase 2,Pandemic H5N1 Influenza,662,Completed
708,709,NCT04749641,Phase 1,Diffuse Intrinsic Pontine Glioma,30,Recruiting
709,710,NCT05161845,Phase 4,Immunotoxicity|Vaccine,1068,Completed
710,711,NCT01636245,Phase 3,"Hand, Foot and Mouth Disease",1400,Completed
711,712,NCT00943358,Phase 1,Influenza,175,Completed
712,713,NCT03956056,Phase 1,Pancreas Cancer|Pancreatic Cancer|Cancer of the Pancreas,12,Terminated
713,714,NCT01529645,Phase 1,Pertussis|Whooping Cough|Tetanus|Lockjaw|Diphtheria,420,Completed
714,715,NCT03391921,Phase 4,HPV - Anogenital Human Papilloma Virus Infection|HIV Infections,170,"Active, not recruiting"
715,716,NCT02045836,Phase 3,Herpes Zoster|Herpes Zoster Vaccine,865,Completed
716,717,NCT00354016,Phase 3,Influenza,125,Completed
717,718,NCT01150695,Phase 2,Tularaemia,228,Completed
718,719,NCT04497298,Phase 1,COVID-19,90,Completed
719,720,NCT01974817,Phase 4,End Stage Renal Disease,25,Completed
720,721,NCT06088563,Not Applicable,Vaccination; Infection,100,Recruiting
721,722,NCT05142488,Phase 4,COVID-19,662,Unknown status
722,723,NCT00971906,Phase 3,Pandemic Influenza,660,Completed
723,724,NCT01943825,Phase 2,Dengue|Dengue Fever|Dengue Hemorrhagic Fever,90,Completed
724,725,NCT01412567,Not Applicable,Chronic Hepatitis B,259,Completed
725,726,NCT01423084,Phase 3,Meningococcal Disease|Meningococcal Meningitis,344,Completed
726,727,NCT01443416,Phase 3,Invasive Streptococcus Pneumoniae Disease,178,Completed
727,728,NCT00971100,Phase 3,Pandemic Influenza,752,Completed
728,729,NCT04998240,Phase 2,Covid19,360,"Active, not recruiting"
729,730,NCT04805931,Not Applicable,Covid19|Vaccine Refusal,4311,Unknown status
730,731,NCT00734175,Phase 1,Influenza|Virus Diseases,22,Completed
731,732,NCT00971542,Phase 3,Pandemic Influenza,778,Completed
732,733,NCT01034358,Phase 4,Inflammatory Bowel Disease|Uterine Cervical Dysplasia,15,Completed
733,734,NCT03630809,Phase 2,"Breast Cancer|HER2-positive Breast Cancer|HER-2 Gene Amplification|HER2 Positive Breast Carcinoma|HER-2 Protein Overexpression|Breast Cancer, Male|Breast Cancer Female",16,Terminated
734,735,NCT03934008,,Vaccine Hesitancy,4191,Completed
735,736,NCT02427581,Phase 1,Triple Negative Breast Cancer|Triple Negative Breast Neoplasms|Triple-Negative Breast Cancer,0,Withdrawn
736,737,NCT02645032,Phase 1,Typhoid,144,Completed
737,738,NCT03525652,Phase 1|Phase 2,Prostate Cancer,30,Unknown status
738,739,NCT03476135,Phase 3,Meningococcal Infections,91,Completed
739,740,NCT05407142,Phase 3,Coronavirus Infections|Vaccine,29000,Recruiting
740,741,NCT05913024,Phase 2,Healthy Volunteers,470,Completed
741,742,NCT01470287,Phase 3,Diphtheria|Tetanus|Pertussis|Hepatitis B|Hemophilus Influenzae B,175,Completed
742,743,NCT01030822,Phase 3,"Infections, Streptococcal",282,Completed
743,744,NCT05293548,Phase 2,COVID-19,516,"Active, not recruiting"
744,745,NCT02919293,Phase 1|Phase 2,Meningitis|Meningococcal Meningitis|Meningococcal Infections,360,Unknown status
745,746,NCT01010893,Not Applicable,Influenza,355,Completed
746,747,NCT02140996,Phase 1,"Epithelial Cancers of the Lung, Breast, Ovary, Prostate and Colon",24,Unknown status
747,748,NCT00175435,Phase 1|Phase 2,Hepatitis B,39,Completed
748,749,NCT02699099,Phase 3,Malaria|Malaria Vaccines,699,Completed
749,750,NCT05405283,Phase 3,COVID-19 Vaccines,189,"Active, not recruiting"
750,751,NCT04822025,Phase 2,Covid19 Vaccine,420,Completed
751,752,NCT06209398,Phase 4,"Hand, Foot and Mouth Disease",510,"Active, not recruiting"
752,753,NCT05026879,,COVID-19|Vaccine Adverse Reaction,4040,Completed
753,754,NCT03903926,Phase 4,"Hand, Foot and Mouth Disease",15500,Completed
754,755,NCT02813486,Phase 1|Phase 2,Tetanus|Diphtheria|Whooping Cough,220,Unknown status
755,756,NCT02348320,Phase 1,Triple Negative Breast Cancer|Triple-Negative Breast Cancer|Triple Negative Breast Neoplasms,18,Completed
756,757,NCT00310635,Phase 4,Meningococcal Infection,241,Completed
757,758,NCT05099029,Phase 3,Enterovirus Infections,3982,Enrolling by invitation
758,759,NCT00788151,Phase 2,Dengue Virus|Dengue Fever|Dengue Hemorrhagic Fever|Dengue Diseases,300,Completed
759,760,NCT01633749,Phase 3,Prophylaxis of Influenza,120,Completed
760,761,NCT00992719,Phase 2,Influenza,84,Completed
761,762,NCT01687517,Phase 3,Sarcoidosis|Influenza Vaccine,190,Completed
762,763,NCT05433272,Phase 3,COVID-19,1400,Not yet recruiting
763,764,NCT04516408,Not Applicable,Herpes Zoster|Recombinant Zoster Vaccine|Systemic Lupus Erythematosus,464,Recruiting
764,765,NCT00197184,Phase 3,Hepatitis B|Hepatitis A,276,Completed
765,766,NCT03627507,Phase 2|Phase 3,Hepatitis B Infection,158,Completed
766,767,NCT00012064,Phase 1|Phase 2,Melanoma (Skin),56,Completed
767,768,NCT00230750,Phase 1|Phase 2,Influenza,261,Completed
768,769,NCT03582761,Phase 4,"Hand, Foot and Mouth Disease",40000,Completed
769,770,NCT04531787,,Influenza,139,Completed
770,771,NCT04695652,Phase 2,Covid19 Vaccine,3854,Completed
771,772,NCT03614533,Phase 2,Typhoid,251,Completed
772,773,NCT05493917,,COVID-19|Vaccine Reaction,2000,Recruiting
773,774,NCT06038617,Phase 4,Fever After Vaccination|Fever|Seizures Fever,600,Recruiting
774,775,NCT00841477,Phase 3,Hepatitis B Infection|Hepatitis C Infection|HIV Infection,1260,Completed
775,776,NCT01214889,Phase 3,Diphtheria|Tetanus|Pertussis|Poliomyelitis|Haemophilus Influenzae Type B,370,Completed
776,777,NCT01187433,Phase 2,Dengue|Dengue Hemorrhagic Fever,150,Completed
777,778,NCT05609994,Phase 1,Low Grade Glioma of Brain,48,Not yet recruiting
778,779,NCT05660408,Phase 1|Phase 2,Pulmonary Osteosarcoma,43,Not yet recruiting
779,780,NCT05526820,Phase 4,Varicella,450,Completed
780,781,NCT01488188,Phase 1,Healthy,40,Completed
781,782,NCT04833101,Phase 4,COVID-19,120,Completed
782,783,NCT04083950,Early Phase 1,Intestinal Permeability|Inflammation|Vaccine|Typhoid Fever,10,"Active, not recruiting"
783,784,NCT04977024,Phase 2,COVID-19 Infection|Hematopoietic and Lymphoid System Neoplasm|Leukemia|Lymphoma|Plasma Cell Myeloma,240,Recruiting
784,785,NCT05332197,Phase 3,Yellow Fever,750,Not yet recruiting
785,786,NCT01506570,Phase 1,Dengue,58,Completed
786,787,NCT00583024,Phase 2,Hormone Refractory Prostate Cancer,32,Completed
787,788,NCT00534833,Phase 3,Diphtheria|Tetanus|Pertussis|Hepatitis B|Haemophilus Influenzae Type b,362,Completed
788,789,NCT00514709,Phase 3,Diphtheria|Tetanus|Pertussis|Hepatitis B|Influenza,1843,Completed
789,790,NCT01949857,Phase 4,Hepatitis A,35000,Completed
790,791,NCT01110551,Phase 1,Dengue,72,Completed
791,792,NCT04613206,Phase 2,Immunization; Infection|Transplantation Infection|Influenza|Solid Organ Transplant,396,Recruiting
792,793,NCT01744171,Phase 1,Recurrent Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin Melanoma,10,Terminated
793,794,NCT00500747,Phase 1,Hepatitis C,60,Completed
794,795,NCT04456504,Phase 4,"Healthcare Worker, Hepatitis B Vaccine, Nonresponder",47,Completed
795,796,NCT04627246,Phase 1,Pancreatic Adenocarcinoma,12,Recruiting
796,797,NCT01465035,Phase 1,Influenza,24,Completed
797,798,NCT05776017,Phase 1|Phase 2,"Malaria,Falciparum",465,Recruiting
798,799,NCT05983874,Phase 1,Hiv,8,Not yet recruiting
799,800,NCT04881227,Not Applicable,Healthcare Workers|Covid19,200,Completed
800,801,NCT03714737,Phase 3,Vaccine,1950,Completed
801,802,NCT01867086,Phase 2,Stage III Ovarian Cancer|Stage IV Ovarian Cancer,1,Completed
802,803,NCT05508178,Phase 1,Norovirus,60,Completed
803,804,NCT00680914,Phase 3,"Infections, Streptococcal",503,Completed
804,805,NCT05048849,Phase 2,Covid19 Vaccine,274,Completed
805,806,NCT03474055,Phase 2|Phase 3,Rotavirus Gastroenteritis,1500,Completed
806,807,NCT03709602,,Human Papilloma Virus,3076,Completed
807,808,NCT03137927,Phase 1,Whooping Cough,36,Completed
808,809,NCT01430611,Phase 4,Meningococcal Disease|Meningitis,666,Completed
809,810,NCT04183114,Phase 2|Phase 3,Congenital Rubella Infection|Measles,540,Completed
810,811,NCT01044199,Not Applicable,Rabies Prevention|Rabies Exposure,130,Completed
811,812,NCT00186927,Phase 1,Parainfluenza|Respiratory Viral Infections,54,Suspended
812,813,NCT00956202,Phase 2,Influenza|Swine-origin A/H1N1 Influenza,303,Completed
813,814,NCT05540522,Phase 3,"Influenza, Human",46180,"Active, not recruiting"
814,815,NCT01404182,Phase 4,Influenza,121,Completed
815,816,NCT05144464,Phase 4,Influenza,240,Enrolling by invitation
816,817,NCT02026089,Phase 4,Persistence of Varicella Immunity,0,Withdrawn
817,818,NCT01507857,Phase 3,"Hand, Foot and Mouth Disease",10077,Completed
818,819,NCT01812980,Phase 4,Influenza|Human Immunodeficiency Virus,105,Completed
819,820,NCT03051516,Phase 4,High Grade Anal Canal Intraepithelial Neoplasia|High Grade Vulvar Squamous Intraepithelial Lesion,188,Terminated
820,821,NCT01877395,Phase 2,Rabies,342,Completed
821,822,NCT00574600,Phase 1,HIV Infections,48,Completed
822,823,NCT00992836,Phase 2,HIV Infections|H1N1 Influenza Virus,155,Completed
823,824,NCT02567955,Phase 3,HPV Vaccines Immunogenicity and Safety,376,Completed
824,825,NCT04706156,,Oral Manifestations|Covid19|Vaccine Adverse Reaction,1540,Unknown status
825,826,NCT01737710,Not Applicable,"Dermatitis, Atopic",368,Completed
826,827,NCT00119197,Phase 2,Cholera,200,Completed
827,828,NCT04350931,Phase 3,Coronavirus Disease (COVID-19),900,Unknown status
828,829,NCT05500482,Phase 4,Typhoid Fever,72500,Recruiting
829,830,NCT05669625,Phase 3,Varicella,12440,"Active, not recruiting"
830,831,NCT01216332,Phase 1,Pediatric Patients With Acute Lymphoblastic Leukemia,50,Completed
831,832,NCT00584844,Phase 2,Tularemia,484,Completed
832,833,NCT01267903,Phase 1,"Hand, Foot and Mouth Disease",100,Completed
833,834,NCT02302170,Phase 3,H. Pylori Infection,4464,Completed
834,835,NCT03962881,Phase 4,Hepatitis B Vaccine,300,Unknown status
835,836,NCT01482052,Phase 1,Meningococcal Meningitis|Meningococcal Infections,60,Completed
836,837,NCT03777163,Phase 4,Influenza,632,Unknown status
837,838,NCT02145624,Phase 4,Responses to Infant Immunisations,366,Completed
838,839,NCT00402649,Phase 1|Phase 2,Influenza,35,Completed
839,840,NCT02787044,Phase 4,Heart Failure|Myocardial Infarction,5388,Completed
840,841,NCT05807035,Phase 1,Solid Tumor,10,Recruiting
841,842,NCT00954798,Phase 2,Influenza|Swine-origin A/H1N1 Influenza,450,Completed
842,843,NCT06078423,Phase 3,Rabies Vaccine Adverse Reaction,1880,Completed
843,844,NCT04072159,Not Applicable,Human Papillomavirus Vaccines,33,Completed
844,845,NCT00627458,Phase 2,Acellular Pertussis|Diphtheria|Poliomyelitis|Haemophilus Influenzae Type b|Tetanus|Hepatitis B,403,Completed
845,846,NCT02741128,Phase 2,Dengue Fever|Dengue Hemorrhagic Fever|Human Immunodeficiency Virus,133,Completed
846,847,NCT00368966,Phase 3,"Vaccines, Pneumococcal",619,Completed
847,848,NCT00657683,Phase 1,Invasive Group B Streptococcus (GBS) Disease,65,Completed
848,849,NCT03888924,Phase 2,Multiple Sclerosis,100,Unknown status
849,850,NCT00359619,Phase 2,"Infections, Papillomavirus|Papillomavirus Vaccines",383,Completed
850,851,NCT05083585,Phase 3,Respiratory Syncytial Virus Prevention,250,Completed
851,852,NCT01507779,Phase 1,Influenza,48,Completed
852,853,NCT01852266,Phase 1,Respiratory Syncytial Virus Infections,50,Completed
853,854,NCT03328325,Phase 4,Influenza|Influenza Immunisation,152,Completed
854,855,NCT03047928,Phase 1|Phase 2,Metastatic Melanoma,50,Recruiting
855,856,NCT00964951,Phase 2,Influenza,0,Withdrawn
856,857,NCT03972813,Not Applicable,Vaccine Refusal,1021,Terminated
857,858,NCT00678301,Phase 3,"Infections, Streptococcal",365,Completed
858,859,NCT05397587,Phase 4,"Hand, Foot and Mouth Disease",474,Not yet recruiting
859,860,NCT00875524,Phase 2,Dengue Virus|Dengue Fever|Dengue Hemorrhagic Fever|Dengue Disease,180,Completed
860,861,NCT01986335,Phase 3,Healthy,600,Completed
861,862,NCT05546502,Phase 3,Vaccine Reaction|Vaccine Adverse Reaction,1050,Recruiting
862,863,NCT04798001,Phase 1,Covid19,130,Recruiting
863,864,NCT04444284,Phase 1,Respiratory Syncytial Virus Infections,34,Completed
864,865,NCT03125473,Phase 1,Norovirus Gastroenteritis,66,Completed
865,866,NCT05273528,Phase 2,COVID-19 Pandemic,20,"Active, not recruiting"
866,867,NCT00994695,Phase 2,Meningococcal Meningitis,412,Completed
867,868,NCT02834637,Phase 3,Human Papilloma Virus,930,"Active, not recruiting"
868,869,NCT01995695,Phase 1,"Influenza A Virus, H7N9 Subtype",48,Completed
869,870,NCT01946425,Phase 4,Influenza,60,Completed
870,871,NCT01554813,Phase 3,Influenza,900,Completed
871,872,NCT03095599,Phase 2|Phase 3,"Influenza, Human",889,Completed
872,873,NCT04364230,Phase 1|Phase 2,Melanoma|Ocular Melanoma|Uveal Melanoma,22,"Active, not recruiting"
873,874,NCT01119482,Phase 4,Meningitis,33000,Completed
874,875,NCT02454634,Phase 1,Glioma,39,Completed
875,876,NCT02542462,Phase 4,Intussusception|Rotavirus Infections,144,Completed
876,877,NCT03468244,Not Applicable,Advanced Esophageal Squamous Carcinoma|Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Colorectal Adenocarcinoma,24,Unknown status
877,878,NCT04895020,Phase 3,HPV Infections|Cervical Cancer|Vulvar Cancer|Vaginal Cancer|CIN1|CIN2|CIN 3|VaIN1|VaIN2|VaIN3|Genital Wart|VIN 1|VIN 2|VIN 3|AIS,1200,Recruiting
878,879,NCT02692599,Phase 3,Mumps,1150,Completed
879,880,NCT01239537,,Influenza,560,Completed
880,881,NCT05047640,Phase 3,Covid19,58,Terminated
881,882,NCT00475033,Phase 3,"Vaccines, Pneumococcal Conjugate Vaccine",603,Completed
882,883,NCT00853255,Phase 1,Influenza|Virus Diseases,20,Completed
883,884,NCT02880865,Phase 4,"Encephalitis, Japanese|Measles|Mumps|Rubella",628,Completed
884,885,NCT01661751,Phase 3,Meningitis,900,Completed
885,886,NCT02596308,Phase 2,Plague,240,Completed
886,887,NCT00880893,Phase 2,Dengue Fever|Dengue Hemorrhagic Fever|Dengue Virus|Dengue Diseases,1198,Completed
887,888,NCT05172193,Phase 2,COVID-19,600,Recruiting
888,889,NCT04908683,Phase 3,Respiratory Syncytial Viruses|Lower Respiratory Tract Disease,25236,Completed
889,890,NCT00363077,Phase 2,Influenza,150,Completed
890,891,NCT00873652,,Healthy,28,Completed
891,892,NCT00532298,Phase 2,Influenza,1596,Completed
892,893,NCT00580684,Phase 4,"Vaccines, Pneumococcal|Vaccines, Pneumococcal Conjugate Vaccine",101,Completed
893,894,NCT02269852,Phase 4,Influenza,182,Completed
894,895,NCT02991599,Phase 4,Hepatitis B Vaccine,196,Completed
895,896,NCT01394640,,Lymphoma|Multiple Myeloma|Myeloproliferative Disease,124,Completed
896,897,NCT01427309,Phase 4,Influenza,31989,Completed
897,898,NCT01378156,Phase 1,HIV-1 Infection,9,Completed
898,899,NCT03807102,Phase 1|Phase 2,Lung Cancer,30,Not yet recruiting
899,900,NCT01359449,Phase 3,Meningitis|Meningococcal Infection,123,Completed
900,901,NCT00963430,Phase 2,Influenza,120,Completed
901,902,NCT04912765,Phase 2,Hepatocellular Carcinoma|Hepatocellular Cancer|Colorectal Cancer|Colorectal Carcinoma|Liver Metastases,60,Recruiting
902,903,NCT00829010,Phase 3,"Infections, Streptococcal",489,Completed
903,904,NCT01688921,Phase 4,"Influenza, Human",1250,Completed
904,905,NCT04410900,Phase 1,B-Cell Neoplasm,43,Recruiting
905,906,NCT02776761,Phase 1,Hantaan Virus,27,Completed
906,907,NCT02114333,Phase 1,Shingles|Herpes Zoster,160,Completed
907,908,NCT00872963,,Malaria,450,Unknown status
908,909,NCT02281396,Phase 1,Rabies|Healthy,40,Completed
909,910,NCT03316807,Phase 4,Hepatitis B Vaccine,182,Completed
910,911,NCT00192413,Phase 3,Influenza,3009,Completed
911,912,NCT01761799,Not Applicable,Influenza|Pertussis,330,Completed
912,913,NCT02325310,Phase 4,Measles|Rubella|Mumps,14,Completed
913,914,NCT01129518,Phase 4,Invasive Meningococcal Disease,404,Completed
914,915,NCT02598089,Phase 1,"Influenza, Human",60,Completed
915,916,NCT02269007,Phase 1,Influenza,110,Completed
916,917,NCT05433285,Phase 3,COVID-19,4050,Completed
917,918,NCT03460405,Phase 2,Safety Issues|Immunogenicity,600,Completed
918,919,NCT00888381,Phase 4,Influenza,120,Completed
919,920,NCT00549900,Phase 1,"Infections, Papillomavirus",30,Completed
920,921,NCT04868448,,Covid19,1600,Unknown status
921,922,NCT01579448,Phase 4,Cholera,426,Completed
922,923,NCT00345319,Phase 3,Rabies Post-exposure Prophylaxis,630,Completed
923,924,NCT04108845,Phase 1,"Pneumonia, Pneumococcal",80,Unknown status
924,925,NCT01411241,Phase 3,Dengue|Dengue Hemorrhagic Fever,720,Completed
925,926,NCT01550289,Phase 2,Dengue|Dengue Fever|Dengue Hemorrhagic Fever,189,Completed
926,927,NCT04084769,Phase 3,Meningococcal Immunisation (Healthy Volunteers),570,Completed
927,928,NCT05745545,Not Applicable,SARS-CoV-2,3200,Recruiting
928,929,NCT02640404,Phase 2,Meningitis|Meningococcal Meningitis|Meningococcal Infections,224,Completed
929,930,NCT02500680,Phase 1,"Influenza, Human",102,Unknown status
930,931,NCT00474526,Phase 3,"Meningitis, Meningococcal",4545,Completed
931,932,NCT00847145,Phase 3,Meningococcal Disease,2249,Completed
932,933,NCT02234921,Phase 1,Adenocarcinoma of the Prostate,3,Completed
933,934,NCT02247362,Phase 1|Phase 2,Influenza,200,Unknown status
934,935,NCT05587881,,Hematologic Diseases,400,Unknown status
935,936,NCT01000207,Phase 2|Phase 3,Swine-Origin Influenza A H1N1 Virus,123,Completed
936,937,NCT02199691,Phase 2,Meningitis|Meningococcal Meningitis|Meningococcal Infections,1715,Completed
937,938,NCT05315856,,COVID-19 Vaccination|Inflammation|Vaccine Immune Response|Vaccine Adverse Reaction,120,Recruiting
938,939,NCT04430907,,HPV Infection,0,Withdrawn
939,940,NCT01625689,Phase 2,Influenza,309,Completed
940,941,NCT01571505,Phase 1,Poliomyelitis|Tropical Enteropathy,372,Completed
941,942,NCT00968890,Phase 2,Influenza,168,Completed
942,943,NCT03739229,Phase 1,Vaccine Adverse Reaction,40,Unknown status
943,944,NCT04934111,Phase 1,COVID-19,42,Recruiting
944,945,NCT01069367,Phase 4,Swine-Origin Influenza A H1N1 Virus,100,Completed
945,946,NCT03300362,Phase 2,Influenza,862,Terminated
946,947,NCT03631043,Early Phase 1,Smoldering Plasma Cell Myeloma,30,"Active, not recruiting"
947,948,NCT01568515,Early Phase 1,"Patient Compliance|Health Knowledge, Attitudes, Practice",283,Completed
948,949,NCT03998592,Phase 1,Rheumatic Fever,0,Withdrawn
949,950,NCT03231605,Phase 4,Hepatitis A,300,Unknown status
950,951,NCT02914184,Phase 3,"Infections, Rotavirus|Rotavirus Vaccines",1612,Completed
951,952,NCT05809752,Phase 1,Leptomeningeal Disease|Triple Negative Breast Cancer|HER2-positive Breast Cancer,18,Recruiting
952,953,NCT05426148,Phase 4,Cervical Intraepithelial Neoplasia|Cervical Cancer|Vaginal Intraepithelial Neoplasia|Vulvar Intraepithelial Neoplasia|Persistent Infection,540,Completed
953,954,NCT01829373,Phase 1,Lung Cancer,5,Completed
954,955,NCT01027845,Phase 3,"Infections, Streptococcal",360,Completed
955,956,NCT00662272,Phase 1,Influenza,128,Completed
956,957,NCT04785794,Phase 1,Influenza Vaccine,122,Completed
957,958,NCT02858570,Phase 2|Phase 3,Serogroup C Meningococcal Meningitis,1644,Unknown status
958,959,NCT04969276,Phase 2,Influenza Immunization|Healthy Volunteers,306,Completed
959,960,NCT02297542,Phase 4,Elderly Immune System,85,Unknown status
960,961,NCT00329927,Phase 2,Influenza,60,Completed
961,962,NCT02405520,Phase 1,Condylomata Acuminata,145,Completed
962,963,NCT05836818,Not Applicable,Influenza Vaccination,767,Completed
963,964,NCT01827839,Phase 3,Herpes Zoster,96,Completed
964,965,NCT01995721,Phase 3,Recurrent Respiratory Papillomatosis,20,Unknown status
965,966,NCT04612972,Phase 3,COVID-19,12000,Completed
966,967,NCT00700193,Phase 3,Influenza,298,Completed
967,968,NCT04576962,,Human Papillomavirus Vaccination,122152,Completed
968,969,NCT04199169,Phase 1,Nipah Virus Infection,192,Completed
969,970,NCT00772070,Phase 2,Meningitis|Meningococcemia|Neisseria Meningitidis,173,Completed
970,971,NCT00244374,Not Applicable,"Medication Adherence|Substance Abuse, Intravenous|Risk Behavior|Hepatitis A|Hepatitis B|Hepatitis C",546,Completed
971,972,NCT01587131,Phase 1,"Influenza, Human|Orthomyxoviridae Infections|RNA Virus Infections|Virus Diseases|Respiratory Tract Infections|Respiratory Tract Diseases",50,Completed
972,973,NCT04951388,Phase 2,Covid19 Vaccine,399,Completed
973,974,NCT05005156,Phase 2,Covid19,876,Unknown status
974,975,NCT06036134,Not Applicable,"Vaccine-Preventable Diseases|COVID-19 Pandemic|Health-Related Behavior|Health Knowledge, Attitudes, Practice|Narration",90,Recruiting
975,976,NCT01502345,Phase 1,Hemorrhagic Fever With Renal Syndrome,31,Completed
976,977,NCT00480454,Phase 1,TB,214,Completed
977,978,NCT02888418,Phase 1,Cervical Cancer,135,Unknown status
978,979,NCT00760825,Phase 4,Vibrio Cholerae,200,Completed
979,980,NCT04811664,Phase 3,SARS-CoV-2 Infection,1923,Completed
980,981,NCT04801667,Phase 4,SARS-CoV Infection|Coronavirus Infection|Vaccine Adverse Reaction,3371,"Active, not recruiting"
981,982,NCT01339923,Phase 3,Meningococcal Disease|Meningococcal Meningitis,1409,Completed
982,983,NCT03122106,Phase 1,Pancreatic Cancer|Pancreas Cancer|Cancer of the Pancreas,15,Terminated
983,984,NCT03357315,Phase 1|Phase 2,Metastatic Sarcoma|Reaction - Mixed Vaccine,30,Completed
984,985,NCT02585700,Phase 1,"Influenza, Human",60,Completed
985,986,NCT03445468,Phase 3,"Influenza, Human",379,Completed
986,987,NCT03357289,Phase 1|Phase 2,Metastasis From Malignant Tumor of Kidney (Disorder)|Reaction - Mixed Vaccine,30,Completed
987,988,NCT04693286,Phase 2,Poliomyelitis,330,Completed
988,989,NCT01044095,Not Applicable,Influenza,26,Completed
989,990,NCT02015091,Phase 1,Malaria,141,Completed
990,991,NCT05482282,Phase 3,Diphtheria Vaccine Adverse Reaction|Tetanus Vaccine Adverse Reaction|Pertussis Vaccine Adverse Reaction|Haemophilus Influenzae Type B Vaccine Adverse Reaction|Hepatitis B Vaccine Adverse Reaction,220,Not yet recruiting
991,992,NCT01752881,Phase 4,Influenza,130,Completed
992,993,NCT00313235,Phase 1|Phase 2,Malignant Melanoma Stage IV,41,Completed
993,994,NCT02285998,Phase 3,Influenza,9003,Completed
994,995,NCT00430521,Phase 2,Influenza|Influenza Vaccines,512,Completed
995,996,NCT01062477,Phase 3,Diphtheria|Tetanus|Pertussis|Haemophilus Influenzae Type B,1056,Completed
996,997,NCT02236052,Phase 2,Virus Diseases|RNA Virus Infections|Respiratory Tract Diseases|Respiratory Tract Infections,450,Completed
997,998,NCT03357276,Phase 1|Phase 2,Metastatic Colorectal Cancer|Reaction - Mixed Vaccine,30,Completed
998,999,NCT00309166,Phase 2,"Infections, Papillomavirus",270,Completed
999,1000,NCT04760132,Phase 4,SARS-CoV Infection,10000,Recruiting
